Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease Grant US-11976334-B2 United States of America 07 May 2024
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors Grant US-11464774-B2 United States of America 11 Oct 2022
Method for treating cancer using a combination of Chk1 and ATR inhibitors Grant US-11179394-B2 United States of America 23 Nov 2021